Generation and immunogenicity of Japanese encephalitis virus envelope protein expressed in transgenic rice

Biochemical and Biophysical Research Communications

Volumn 380, Issue 2, 2009, Pages 292-297

  Wang, Yuanyuan ^a   Deng, Hanqing ^a   Zhang, Xiaobo ^a   Xiao, Hailin ^a   Jiang, Yunbo ^a   Song, Yunfeng ^a   Fang, Liurong ^a   Xiao, Shaobo ^a   Zhen, Yonglian ^a   Chen, Huanchun ^a  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

Envelope protein; Immunogenicity; Japanese encephalitis virus (JEV); Transgenic rice

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; JAPANESE ENCEPHALITIS VACCINE; JAPANESE ENCEPHALITIS VIRUS ENVELOPE PROTEIN; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAULIFLOWER MOSAIC VIRUS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC ENCEPHALITIS; FEMALE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; JAPANESE ENCEPHALITIS VIRUS; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; NORTHERN BLOTTING; PLANT LEAF; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHIZOBIUM; RICE; SOUTHERN BLOTTING; VACCINATION; WESTERN BLOTTING;

ADMINISTRATION, ORAL; ANIMALS; IMMUNIZATION; IMMUNOGLOBULIN G; JAPANESE ENCEPHALITIS VACCINES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; ORYZA SATIVA; PLANTS, GENETICALLY MODIFIED; VACCINES, EDIBLE; VIRAL ENVELOPE PROTEINS;

AGROBACTERIUM; CAULIFLOWER MOSAIC VIRUS; JAPANESE ENCEPHALITIS VIRUS; MUS;

EID: 60349086547     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.01.061     Document Type: Article

References (30)

1. World Health Organization, Japanese encephalitis vaccines, Wkly. Epidemiol. Rec. 73 (1998) 334-344.
2. Plesner A.M., and Ronne T. Allergic mucocutaneous reactions to Japanese encephalitis vaccine. Vaccine 15 (1997) 1239-1243
3. Tsai T.F. New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, 13-15 October 1998. Vaccine 18 (2000) 1-25
4. Tacket C.O., Mason H.S., Losonsky G., Estes M.K., Levine M.M., and Arntzen C.J. Human immune responses to a novel Norwalk virus vaccine delivered in transgenic potatoes. J. Infect. Dis. 182 (2000) 302-305
5. Streatfield S.J. Mucosal immunization using recombinant plant-based oral vaccines. Methods 38 (2006) 150-157
6. He D.M., Qian K.X., Shen G.F., Li Y.N., Zhang Z.F., Su Z.L., and Shao H.B. Stable expression of foot-and-mouth disease virus protein VP1 fused with cholera toxin B subunit in the potato (Solanum tuberosum). Colloids Surf. B Biointerfaces 55 (2007) 159-163
7. Brown F. Vaccination against foot and mouth disease virus. Vaccine 10 (1992) 1022-1026
8. Carrillo C., Wigdorovitz A., Oliveros J.C., Zamorano P.I., Sadir A.M., et al. Protective immune response to foot and mouth disease virus with VP1 expressed in transgenic plants. J. Virol. 72 (1998) 1688-1690
9. Dus Santos M.J., Wigdorovitz A., Trono K., Rios R.D., Franzone P., Carrillo C., et al. A novel methodology to develop a foot and mouth disease virus (FMDV) peptide-based vaccine in transgenic plants. Vaccine 20 (2002) 1141-1147
10. Haq T.A., Mason H.S., Clements J.D., and Arntzen C.J. Oral immunization with recombinant bacterial antigen produced in transgenic plants. Science 28 (1995) 714-716
11. Wigdorovitz A., Carrillo C., Dus Santos M.J., Sadir A.M., Rios R., Franzone P., et al. Induction of a protective antibody response to foot and mouth disease virus in mice following oral or parenteral immunized with alfalfa transgenic plants expressing the viral structural protein VP1. Virology 255 (1999) 347-353
12. Arakawa T., Chong D.K.X., and Langridge W.H.R. Efficacy of a food plant-based oral cholera toxin B subunit vaccine. Nat. Biotechnol. 16 (1998) 292-297
13. Mason H.S., Ball J.M., Shi J., Jiang X., Estes M.K., and Arntzen C.J. Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity. Proc. Natl. Acad. Sci. USA 93 (1996) 5335-5340
14. Kapusta J., Modelska A., Filgerowicz M., Pniewski T., Letellier M., Lisowa O., et al. A plant-derived edible vaccine against hepatitis B virus. FASEB J. 13 (1999) 1796-1799
15. Warzecha H., Mason H.S., Lane C., Tryggvesson A., Rybicki E., Williamson A.L., et al. Oral immunogenicity of human papillomavirus-like particles expressed in potato. J. Virol. 77 (2003) 8702-8711
16. Hiei Y., Ohta S., Komari T., and Kumashiro T. Efficient transformation of rice (Oryza sativa L.) mediated by Agrobacterium and sequence analysis of the boundaries of the T-DNA. Plant J. 6 (1994) 271-282
17. Berinstein A., Vazquez-Rovere C., Asurmendi S., Gómez E., Hopp E., Carrillo E., et al. Mucosal and systemic immunization elicited by Newcastle disease virus (NDV) transgenic plants as antigens. Vaccine 23 (2005) 5583-5589
18. Wu Y.Z., Li J.T., Mou Z.R., Fei L., Ni B., Geng M., Jia Z.C., Zhou W., and Tang Y. Oral immunization with rotavirus VP7 expressed in transgenic potatoes induced high titers of mucosal neutralizing IgA. Virology 313 (2003) 337-342
19. Fang L.R., Jiang Y.B., Xiao S.B., Niu C.S., Zhang H., and Chen H.C. Enhanced immunogenicity of the modified GP5 of porcine reproductive and respiratory syndrome virus. Virus Genes 32 (2006) 5-11
20. Ostrowski M., Galeota J.A., Jar A.M., Platt K.B., Osorio F.A., and Lopez O.J. Identification of neutralizing and nonneutralizing epitopes in the porcine reproductive and respiratory syndrome virus GP5 ectodomain. J. Virol. 76 (2002) 4241-4250
21. Lal P., Ramachandran V.G., Goyal R., and Sharma R. Edible vaccine: current status and future. Indian J. Med. Microbiol. 25 (2007) 93-102
22. Ritcher L.J., Thanavala Y., Arntzen C.J., and Mason H.S. Production of hepatitis B surface antigen in transgenic plants for oral immunization. Nat. Biotechnol. 18 (2000) 1167-1171
23. Walmsley A.M., and Arntzen C.J. Plant cell factories and mucosal vaccines. Curr. Opin. Biotechnol. 14 (2003) 145-150
24. Streatfield S.J., Mayor J.M., Barker D.K., Brooks C., Lamphear B.J., Woodard S.L., Beifuss K.K., Vicuna D.V., Horn M.E., et al. Development of an edible subunit vaccine in corn against enterotoxigenic strains of Escherichia coli. In Vitro Cell Dev. Biol. Plant 38 (2002) 11-17
25. Chikwamba R.K., Cunnick J., Hathaway D., McMurray J., Mason H.S., and Wang K. A functional antigen in a practical crop: LT-B-producing maize protects mice against Escherichia coli heat labile enterotoxin (LT) and cholera toxin (CT). Transgenic Res. 11 (2002) 479-493
26. Yang L.J., Kajiura H., Suzuki K., Hirose S., Fujiyama K., and Takaiwa F. Generation of a transgenic rice seed-based edible vaccine against house dust mite allergy. Biochem. Biophys. Res. Commun. 365 (2008) 334-339
27. Rauthan M., Kaur R., Appaiahgari M.B., and Vrati S. Oral immunization of mice with Japanese encephalitis virus envelope protein synthesized in Escherichia coli induces anti-viral antibodies. Microbes Infect. 6 (2004) 1305-1311
28. Kaur R., Sachdeva G., and Vrati S. Plasmid DNA immunization against Japanese encephalitis virus: immunogenicity of membrane-anchored and secretory envelope protein. J. Infect. Dis. 185 (2002) 1-12
29. Ramakrishna C., Desai A., Shankar S.K., Chandramuki A., and Ravi V. Oral immunisation of mice with live Japanese encephalitis virus induces a protective immune response. Vaccine 17 (1999) 3102-3108
30. Wu S.C., Lin Y.J., and Yu C.H. Baculovirus-insect cell expression, purification, and immunological studies of the full-length Japanese encephalitis virus envelope protein. Enzyme Microb. Technol. 33 (2003) 438-444